Our purpose was accelerating the physiologic wound healing, stimulating tissue regeneration and the reparative tissue processes in resistant skin ulcers as in a case of an erosive lichen planus of the soles and after a surgical treatment as for severe Darier disease. The challenge was to establish an effective therapy to enhance tissue healing by the injection of a mixture of peripheral blood mononuclear cells (PB-MNCs) and platelet-rich plasma (PRP) into a skin autograft area.
| BACKG ROU N D
Platelet growth factors (GFs) of alpha and dense granules and antiinflammatory mediators in platelet-rich plasma (PRP) are biologically active peptides that enhance tissue repair mechanisms (as angiogenesis, extracellular matrix remodelling), and cooperate in cellular effects, as stem cells recruitment, chemotaxis, cell proliferation and differentiation. [1] [2] [3] The contribution of PRP in promoting tissue healing can be combined with cell-based therapies such as adiposederived stem cells or regenerative cell therapy. [1] Peripheral blood mononuclear cells (PB-MNCs), in particular the monocyte lineage, may play a role in the epithelialisation, granulation tissue formation and neovascularisation; this producing different cytokines within their cell secretome, [4] by cellular differentiation developing an epithelial-like profile, [5] and through the dynamic changes of macrophages during different phases of wound healing. [6] The co-culture of PB-MNCs with platelet gel suggests the capacity of influence the whole process of tissue regeneration. [7, 8] Autologous PRP, as a rapid and safe accelerator of the healing process, has different clinical applications, in chronic and acute wound repair as well as in dental implant surgery and bone regeneration, aesthetic procedures, eye, cardiac and orthopaedic surgery, muscle and tendon repair also in sports injuries. [3, 9] Based on our experience and literature review, postoperative complications as infections or necrosis of the skin autograft are considerable risks in the surgical treatment of particular skin conditions, as unresponsive ulcers in erosive plantar lichen planus or severe Darier disease.
[10]
Hence, we proposed a combined treatment option, reinforcing the surgery with the positive effects of PRP and total nucleated cells (TNCs) in terms of decreased infection risks, exudate, haematomas, level of pain, increased velocity and chance of complete wound healing, better cutaneous trophism and final scar. [9, 11] We present our preliminary observations with this innovative approach.
| QUE S TIONS ADDRE SS ED
Our purpose was the evaluation of a novel combined approach in tissue repair: skin grafting associated with the injection of PB-MNCs in a scaffold of autologous PRP during covering of surgical wound sites.
| E XPERIMENTAL DE S I G N
PB-MNCs were isolated from non-pathologic whole peripheral blood of the patients using Pall Celeris TM gravity filtration system.
A blood sample (50 mL) is transferred to a sample input bag connected to a filter. The sample flows through the filter, and TNCs are captured on the filter material. The majority of the plasma, red blood cells and platelets pass through the filter into the filtrate bag below. The captured cells are collected by back-flushing the filter (reversing the direction of the flow) with a saline solution (10 cc) and the released cells flow into an attached collection bag. This is the enriched TNC population. [12] At the same time, another peripheral venous blood was drawn and PRP was created using a centrifugation system. Then, we mixed the solution with autologous PRP (2:1 ratio of TNCs to PRP), and we injected it through a 25 gauge needle along the margins and inside of the wound bed in small amounts (0.1 mL). The protocol required the use of a more represented cellular component associated with a half quantity of PRP, to stimulate cellular proliferative activity through the GFs released by platelet alpha-granules.
| RE SULTS
An 81-year-old woman was referred to our centre with relapsing This treatment produced a rapid clinical improvement with complete healing within 3 weeks ( Figure 1C ). We administered a short course of a 2 days postprocedural light analgesia, observing the rapid effect of PRP also in reducing pain. [13, 14] Four years later, the treated areas were free of recurrences.
A 63-year-old woman presented to our centre with multiple painful and itching, reddish-yellowish hyperkeratotic papules, either isolated either coalesced to form warty plaques, partially disepithelised and exudative or covered by thick crusts, involving the lower limbs, trunk, genital and gluteal region (Figure 2A ), diagnosed as Darier disease (with multiple histopathological confirmations). In the past, she was treated with oral retinoids for 35 years, and later with CO2 laser, hyperbaric oxygen therapy and systemic steroids associated with topical medications without any significant improvement. Thus, we considered the surgical strategy with the wide excision of diseased skin of the tights and covering with a meshed split-thickness skin autograft associated with infiltrations of PB-MNCs in autologous PRP ( Figure 2B ). The treated areas were epithelialised without any sign of infection 3 weeks later, free of disease recurrence also at a 1-year follow-up ( Figure 2C ), although the disease was still present in other parts of the body.
| CON CLUS IONS
The success of our strategy, that fuses and amplifies the known stimulation and acceleration of tissue healing in particularly complex skin conditions. We applied this procedure not only to a refractory cutaneous ulcer in the erosive lichen planus, but also to wide lesions in Darier disease. This combined technique could be suggested in selected cases where there is a consistent risk of failure of the single surgical treatment, because of the type and aetiology of the skin disease, the unresponsiveness to previous therapies, the localisation and width of the surgical site, considering also eventual postoperative complications and pain level. Hence, this procedure is expected to enhance the autografting with the wide range of above described positive effects of PRP and PB-MNCs. [9, 11, 15, 16] The present paper suffers from limitations, as the small sample size and the absence of a control group, but here we present our preliminary observations with this innovative approach. Future researches should explore systematically the efficacy and clinical relevance of this procedure and evaluate its long-term benefit.
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